anti-Synovial Sarcoma, X Breakpoint 2 (SSX2) Antikörper

The product of SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. Zusätzlich bieten wir Ihnen Synovial Sarcoma, X Breakpoint 2 Proteine (7) und Synovial Sarcoma, X Breakpoint 2 Kits (1) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
SSX2 6757 Q16385
SSX2 103690782  
SSX2    
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-Synovial Sarcoma, X Breakpoint 2 Antikörper auf antikoerper-online.de

Showing 10 out of 82 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Human Kaninchen Unkonjugiert WB WB Suggested Anti-SSX2 Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:312500  Positive Control:  Jurkat cell lysate Host:  Rabbit  Target Name:  SSX2  Sample Tissue:  Human Jurkat  Antibody Dilution:  1.0ug/ml 100 μL 2 bis 3 Tage
$319.00
Details
Human Kaninchen Unkonjugiert WB Host: Rabbit Target Name: SSX2 Sample Type: Lung Tumor lysates Antibody Dilution: 1.0ug/ml 100 μL 2 bis 3 Tage
$289.00
Details
Human Maus Unkonjugiert IF, IHC, IHC (p), WB 100 μL 11 bis 14 Tage
$522.50
Details
Human Maus Unkonjugiert IHC (p), ELISA, WB Detection limit for recombinant GST tagged SSX2 is approximately 0.03ng/ml as a capture antibody. Western Blot analysis of SSX2 expression in transfected 293T cell line by SSX2 monoclonal antibody (M01), clone 1A4.Lane 1: SSX2 transfected lysate(25.2 KDa).Lane 2: Non-transfected lysate. 100 μg 11 bis 12 Tage
$440.00
Details
Human Kaninchen Unkonjugiert IHC (p), WB Anti-SSX2 antibody, IHC(P) IHC(P): Human Intestinal Cancer Tissue Anti-SSX2 antibody, Western blotting Lane 1: MCF-7 Cell Lysate Lane 2: HELA Cell Lysate 100 μg 4 bis 6 Tage
$280.00
Details
Human Kaninchen Unkonjugiert WB SSX2 Polyclonal Antibody 0.1 mg 6 bis 8 Tage
$456.50
Details
Human Kaninchen Unkonjugiert WB   100 μg 11 bis 14 Tage
$881.83
Details
Human Maus Unkonjugiert IF, IHC, WB Immunohistochemical staining of paraffin-embedded Adenocarcinoma of breast tissue using anti-SSX2 mouse monoclonal antibody. (ABIN2452635, Dilution 1:50) Immunohistochemical staining of paraffin-embedded colon tissue using anti-SSX2mouse monoclonal antibody. (ABIN2452635, Dilution 1:50) 0.1 mL 2 bis 3 Tage
$462.00
Details
Human Maus Unkonjugiert WB Western Blot analysis of SSX2 expression in transfected 293T cell line by SSX2 MaxPab polyclonal antibody.Lane 1: SSX2 transfected lysate(24.53 KDa).Lane 2: Non-transfected lysate. 50 μL 11 bis 12 Tage
$440.00
Details
Human Kaninchen Unkonjugiert IHC, WB Western blot analysis of extracts of HeLa cells, using SSX2 antibody (ABIN5974203) at 1/1000 dilution. Immunohistochemistry of paraffin-embedded human colon carcinoma using SSX2 antibody (ABIN5974203) at dilution of 1/200 (40x lens). 100 μL 11 bis 16 Tage
$426.40
Details

Am meisten referenzierte anti-Synovial Sarcoma, X Breakpoint 2 Antikörper

  1. Human Monoclonal SSX2 Primary Antibody für IHC (p), ELISA - ABIN520520 : Smith, Cronk, Lang, McNeel: Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer. in Cancer research 2011 (PubMed)
    Show all 2 Pubmed References

  2. Human Polyclonal SSX2 Primary Antibody für WB - ABIN2780224 : Fernebro, Francis, Edén, Borg, Panagopoulos, Mertens, Vallon-Christersson, Akerman, Rydholm, Bauer, Mandahl, Nilbert: Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. in International journal of cancer. Journal international du cancer 2005 (PubMed)
    Show all 2 Pubmed References

Weitere Antikörper gegen Synovial Sarcoma, X Breakpoint 2 Interaktionspartner

Human Synovial Sarcoma, X Breakpoint 2 (SSX2) Interaktionspartner

  1. co-expression of and interplay between Rab3IP and SSX2 during gastric cancer progression

  2. We conclude from these findings that SSX2 expression in prostate cancer is not a driver of the epithelial to mesenchymal transition (EMT), but is involved in processes associated with EMT including loss of focal adhesion that may be related to tumor cell dissemination

  3. Meta-analysis of human synovial sarcoma patient series identified two tumor-gentoype-phenotype correlations that were not modeled by the mice, namely a scarcity of male hosts and biphasic histologic features among SS18-SSX2 tumors. Re-analysis of human SS18-SSX1 and SS18-SSX2 tumor transcriptomes demonstrated very few consistent differences, but highlighted increased native SSX2 expression in SS18-SSX1 tumors.

  4. results reveal two important phenotypes of ectopic SSX2 expression that may drive/support tumorigenesis: First, immediate induction of genomic instability, and second, long-term support of tumor cell growth.

  5. The tumor-specific pattern of expression of SSX2.

  6. primary autoantibodies against intracellular MM-specific tumor antigens SSX-2 and NY-ESO-1 are rare but functional in multiple myeloma patients after allogeneic stem cell transplantation

  7. SS18-SSX-induced Wnt/beta-catenin signaling appears to be of crucial biological importance in synovial sarcoma tumorigenesis and progression.

  8. SSX2, SSX3, and SSX4 are expressed in the lung tissue of only 3.5% early-stage non-small cell lung cancer patients.

  9. These results suggest that the characteristic speckle localization pattern of SS18-SSX is strongly involved in the tumorigenesis through the SSX moiety of the SS18-SSX fusion protein.

  10. the initial events that likely occur when SYT-SSX2 is first expressed, and its dominant function in subverting the nuclear program of the stem cell, leading to its aberrant differentiation, as a first step toward transformation

  11. The regulation of estrogen receptor alpha signaling by target proteins of SSX2 may explain the metastatic potential of breast cancer cells.

  12. The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RABIN3, and a novel nuclear protein, SSX2IP.

  13. existence of fusion with SYT in synovial sarcoma

  14. We report the identification of an HLA-DR3-restricted epitope mapping to the 37-51 region of SSX-2.

  15. RT-PCR detection of SSX2 in paraffin-embedded tissue allowed for molecular diagnosis of synovial sarcoma.

  16. demonstrate differentially expressed genes for the 2 major gene fusion variants in SS, chromosome 18 synovial sarcoma (SS18)/SSX1 and SS18/SSX2, and thereby suggest that these result in different downstream effects

  17. Two kinds of cancer-testis antigen, SSX-2 and SSX-5 showed high-specific and high-frequent expression in hepatocellular carcinoma tissues, but neither of them could be detected in adjacent non-HCC tissues.

Synovial Sarcoma, X Breakpoint 2 (SSX2) Antigen-Profil

Protein Überblick

The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X\\\\;18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene.

Genbezeichner und Symbole assoziert mit SSX2

  • SSX family member 2 (SSX2) Antikörper
  • protein SSX2 (LOC741661) Antikörper
  • synovial sarcoma, X breakpoint 2 (Ssx2) Antikörper
  • CT5.2 Antikörper
  • CT5.2A Antikörper
  • HD21 Antikörper
  • HOM-MEL-40 Antikörper
  • SSX Antikörper
  • SSX2 Antikörper
  • SSX3 Antikörper

Bezeichner auf Proteinebene für SSX2

cancer/testis antigen 5.2 , cancer/testis antigen family 5, member 2a , protein SSX2 , sarcoma, synovial, X-chromosome-related 2 , synovial sarcoma, X breakpoint 2B , tumor antigen HOM-MEL-40 , synovial sarcoma, X breakpoint 2 , synovial sarcoma, X breakpoint 3 , protein SSX1 , putative protein SSX10 , putative protein SSX6-like

GENE ID SPEZIES
6757 Homo sapiens
741661 Pan troglodytes
103690782 Rattus norvegicus
Ausgewählte Anbieter für anti-Synovial Sarcoma, X Breakpoint 2 (SSX2) Antikörper
Haben Sie etwas anderes gesucht?